Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients
about
The detection, treatment, and biology of epithelial ovarian cancerThe mechanisms by which polyamines accelerate tumor spread.TCR zeta-chain downregulation: curtailing an excessive inflammatory immune response.Epigenetic biomarkers of T-cells in human glioma.Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets.Effector CD8+CD45RO-CD27-T cells have signalling defects in patients with squamous cell carcinoma of the head and neck.Covert operations: cancer's many subversive tactics in overcoming host defenses.Role of prolactin receptor and CD25 in protection of circulating T lymphocytes from apoptosis in patients with breast cancer.Exosomes/microvesicles: mediators of cancer-associated immunosuppressive microenvironments.Recovery of zeta-chain expression and changes in spontaneous IL-10 production after PSA-based vaccines in patients with prostate cancerExtracellular 2'5'-oligoadenylate synthetase 2 mediates T-cell receptor CD3-ζ chain down-regulation via caspase-3 activation in oral cancer.Regulation of T cell receptor CD3zeta chain expression by L-arginine.Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.Tumor-dependent down-regulation of the ζ-chain in T-cells is detectable in early breast cancer and correlates with immune cell function.JAK3, STAT3 and CD3-zeta signaling proteins status in regard to the lymphocytes function in patients with ovarian cancer.
P2860
Q21198791-84A86038-BC2A-4D18-9B7B-C2F6ECA60B5DQ35505118-8C5A84E4-332A-40D9-B503-52CD3AE6F4C0Q35877202-A7A29FD1-D741-4E3E-AE40-30E2892A2DB0Q36484129-F5A2E26A-0CCE-4012-BA1A-BD423D9133DCQ36542190-FC678444-C9D7-436D-948D-2E9799417042Q36648706-B34ED948-942B-47D5-913E-484EF3F76D54Q37026063-E4F7CF37-24DD-4C78-8301-D8A577D5624AQ37355075-CFB77544-D4F1-4498-B11D-24087CF13B8DQ37891886-DA3E3864-6EA7-46C7-81A0-B32046FA807DQ38281731-1F54EF48-83CC-483C-8D69-AB8E7DE0E7B9Q38817649-824E42A7-0CC3-4AEE-90EA-B08642DC9494Q43957769-550E085E-57F1-4D2C-9DF6-85BEBA99E59BQ44638209-05B93409-59B3-4D3B-9F11-9172E15ED549Q50997188-3F45FB01-26F6-4293-870F-55C3C0523B9DQ54538366-6EB64F01-EA32-4601-AA58-B3AC45E95572
P2860
Modulation of TcR/CD3-zeta chain expression by a circulating factor derived from ovarian cancer patients
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
2001年论文
@zh
2001年论文
@zh-cn
name
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@ast
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@en
type
label
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@ast
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@en
prefLabel
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@ast
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@en
P2093
P2860
P356
P1476
Modulation of TcR/CD3-zeta cha ...... d from ovarian cancer patients
@en
P2093
Gerçel-Taylor C
Whiteside TL
P2860
P2888
P304
P356
10.1054/BJOC.2001.1847
P407
P577
2001-06-01T00:00:00Z
P5875
P6179
1038794005